PremiumCompany Announcements3SBio, Inc. Reports Strong Financial Growth in 2024 3SBio Announces Strong Financial Results for 2024 3SBio Announces Final Dividend for 2024 PremiumCompany Announcements3SBio CFO Boosts Shareholding, Confident in Future 3SBio Secures Exclusive Rights for Cancer Drug 3SBio Issues Supplemental Share Grant Info PremiumCompany Announcements3SBio Inc. Announces Board Composition Details 3SBio Subsidiary Strikes Key Weight Management Drug Deal 3SBio Inc. Schedules Annual General Meeting